CSF2 and myeloid sarcoma: In addition to the cytokines included in the FluoroSpot analysis, we wanted to explore whether granulocyte-macrophage colony-stimulating factor (GM-CSF)–producing cells were targeting autoantigens specifically, as GM-CSF–producing CD4+ T cells have recently been demonstrated to be selectively increased in MS (33).